MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases
- PMID: 21909877
- PMCID: PMC3170419
- DOI: 10.1007/s12307-011-0062-y
MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases
Abstract
The influence of the microenvironment through the various steps of cancer progression is signed by different cytokines and growth factors, that could directly affect cell proliferation and survival, either in cancer and stromal cells. In colon cancer progression, the cooperation between hypoxia, IL-6 and VEGF-A165 could regulate the DNA repair capacity of the cell, whose impairment is the first step of colon cancer development. This cooperation redirects the activity of proteins involved in the metabolic shift and cell death, affecting the cell fate. The pathways triggered by micro environmental factors could modulate cancer-related gene transcription, affecting also small non coding mRNA, microRNAs. MicroRNAs have emerged as key post-transcriptional regulators of gene expression, directly involved in human cancers. The present review will focus first on the intertwined connection between cancer microenvironment and aberrant expression of microRNAs which contribute to carcinogenesis. In particular, the epigenetic mechanisms triggered by tissue microenvironment will be discussed, in view of the recent identification of miRNAs able to directly or indirectly modulate the epigenetic machinery (epi-miRNAs) and that are involved in the epithelial to mesenchimal transition and metastases development.
Figures

Similar articles
-
A microRNA component of the neoplastic microenvironment: microregulators with far-reaching impact.Biomed Res Int. 2013;2013:762183. doi: 10.1155/2013/762183. Epub 2012 Dec 4. Biomed Res Int. 2013. PMID: 23509776 Free PMC article. Review.
-
MicroRNA Targeting to Modulate Tumor Microenvironment.Front Oncol. 2016 Jan 19;6:3. doi: 10.3389/fonc.2016.00003. eCollection 2016. Front Oncol. 2016. PMID: 26835418 Free PMC article. Review.
-
A step-by-step microRNA guide to cancer development and metastasis.Cell Oncol (Dordr). 2017 Aug;40(4):303-339. doi: 10.1007/s13402-017-0341-9. Epub 2017 Jul 26. Cell Oncol (Dordr). 2017. PMID: 28748501 Review.
-
A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.Tumour Biol. 2017 May;39(5):1010428317695032. doi: 10.1177/1010428317695032. Tumour Biol. 2017. PMID: 28468581 Review.
-
Targeting the Metastatic Bone Microenvironment by MicroRNAs.Front Endocrinol (Lausanne). 2018 Apr 27;9:202. doi: 10.3389/fendo.2018.00202. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29780354 Free PMC article. Review.
Cited by
-
The role of microRNA-26a in human cancer progression and clinical application.Tumour Biol. 2016 Jun;37(6):7095-108. doi: 10.1007/s13277-016-5017-y. Epub 2016 Apr 2. Tumour Biol. 2016. PMID: 27039398 Review.
-
miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases.Mol Cancer Ther. 2018 Jan;17(1):130-139. doi: 10.1158/1535-7163.MCT-17-0042. Epub 2017 Oct 27. Mol Cancer Ther. 2018. PMID: 29079708 Free PMC article.
-
Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.Front Oncol. 2022 Nov 22;12:1042196. doi: 10.3389/fonc.2022.1042196. eCollection 2022. Front Oncol. 2022. PMID: 36483029 Free PMC article. Review.
-
Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.Oncotarget. 2015 Dec 29;6(42):44758-80. doi: 10.18632/oncotarget.5815. Oncotarget. 2015. PMID: 26556872 Free PMC article.
-
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.Curr Pharm Des. 2013;19(4):578-613. doi: 10.2174/138161213804581918. Curr Pharm Des. 2013. PMID: 23016851 Free PMC article. Review.
References
-
- Jass JR. Colorectal cancer: a multipathway disease. Crit Rev Oncog. 2006;12:273–287. - PubMed
-
- Finlay GJ. Genetics, molecular biology and colorectal cancer. Mutat Res. 1993;290:3–12. - PubMed
-
- Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160. doi: 10.3322/CA.2007.0018. - DOI - PubMed
-
- Bousserouel S, Kauntz H, Gossé F, Bouhadjar M, Soler L, Marescaux J, Raul F. Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis. Int J Oncol. 2010;36(6):1485–1490. - PubMed
LinkOut - more resources
Full Text Sources